World Health Organization Says No To Delayed Disclosure Of Clinical Trials
This article was originally published in The Gray Sheet
Executive Summary
The World Health Organization has decided that the public's need for transparency in clinical trials trumps industry concerns that early disclosure of certain information could undercut a company's competitive advantage
You may also be interested in...
Public Registration Of Device Trials Increases 10-Fold In Two Years
Registration of medical device trials on a government Web site increased more than 10-fold in the past two years, and legislation moving through Congress is likely to expand that activity even further
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.